MetaCap

CytomX Therapeutics Earnings

NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.57+0.10 (+4.05%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.09

CytomX Therapeutics earnings summary

CytomX Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.09.

Summary generated from market data by MetaCap's automated system. Methodology

Related